Skip to content

European Society of Intensive Care Medicine study of therapeutic hypothermia (32-35 degrees Celsius) for ICP reduction after traumatic brain injury

European Society of Intensive Care Medicine study of therapeutic hypothermia (32-35 degrees Celsius) for ICP reduction after traumatic brain injury - EUROTHERM3235

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38267
Enrollment
50
Registered
2012-03-19
Start date
2013-03-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain concussion brain injury

Interventions

Therapeutic hypothermia between 32 and 35 degrees Celsius to lower ICP to below 20 mmHg

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.18 years of age or older 2.primary closed traumatic brain injury 3.raised ICP>20mmHg 4. up to 10 days after initial head injury 5.cooling device or technique available for at least 48 hours 6.core temperature 36 degrees Celsius or higher at the time of randomisation 7.abnormal CT of the brain

Exclusion criteria

Exclusion criteria: 1.already receiving therapeutic hypothermia 2.barbiturate therapy prior to inclusion 3.unlikely to survive in next 24 hours according to ICU consultant or neurosurgeon 4.temperature 34 degrees or less at admission 5.pregnancy

Design outcomes

Primary

MeasureTime frame
outcome at 6 months using the extended Glasgow Outcome Scale (GOSE) questionnaire

Secondary

MeasureTime frame
6 month mortality rate, intracranial pressure control, incidence of pneumonia, length of stay in hospital and ICU, Modified Oxford Handicap Scale score at one month, discharge from randomising hospital or death whichever occurs first, correlation betweenpredicted outcome using mOxford Handicap Scale at discharge from hospital and the GOSE Score at 6 months and health economics

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)